Shanghai Henlius Biotech Renews Distribution Agreement with Sinopharm
I'm PortAI, I can summarize articles.
Shanghai Henlius Biotech Inc. has renewed its distribution agreement with Sinopharm Group, signing a new framework on December 3, 2025. This extends their partnership, with transactions conducted in the ordinary course of business. An Independent Board Committee will advise shareholders on the agreement's fairness. The news was generated by Public Technologies using AI and is for informational purposes only.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments